One Dose of Psilocybin in Late Adolescence Mitigates Deleterious Effects of Developmental Stress on Cognition and Behavioral Despair in Adult Female Rats
Meghan Hibicke, Charles D. Nichols
The FASEB Journal April 1, 2020 DOI: 10.1096/fasebj.2020.34.s1.02912 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Randomized controlled trial Peer reviewed |
|---|---|
| Population | Adolescent female Sprague Dawley rats |
| Intervention | Psilocybin |
| Dose | 1 mg/kg |
| Duration | Single dose on postnatal day 52, with behavioral testing from postnatal days 82-90 |
| Topics | Psilocybin |
| Keywords | Antidepressant Behavioural despair test Dentate gyrus Cognition Hippocampus Chronic stress Schizophrenia object-oriented programming |
| Citations | 9 |
| Key findings | A single dose of psilocybin normalized object pattern separation performance and forced swim test immobility in adolescent female rats subjected to chronic restraint stress. |
Abstract
Introduction: Psilocybin (PSI) has persistent antidepressant efficacy in human trials. We have shown one dose of PSI to significantly decrease depressive‐like behavior in male Wistar‐Kyoto (WKY) rats for at least five weeks without losing efficacy. However, the outcome assay we used to evaluate depressive‐like behavior, the forced swim test (FST), has been criticized for not providing circuit‐specific endpoint data. Further, rodent strains like WKY selectively bred for face validity in modeling depression have lower translational value than chronic/developmental stress models. Pattern separation is a function of the dentate gyrus (DG) and CA3 region of the hippocampus. Pattern separation deficits are measurable in a number of psychological and neurological disorders where the DG‐CA3 circuit is impaired, including major depressive disorder, schizophrenia, and age‐related dementias. The object pattern separation (OPS) task is a new paradigm to measure DG‐CA3 function in rodents, proposed as a cognitive‐based outcome measure for depression‐like phenotypes, but so far only used in healthy male animals. Whether OPS performance correlates with established measures of behavioral despair, or can be normalized by human pharmacotherapies, is unknown.
Objectives: Evaluate long‐term antidepressant‐like effects of PSI in the stress‐based adolescent chronic restraint stress (aCRS) model for depression, establish face and predictive validity of the OPS task, and determine whether OPS correlates with FST immobility in aCRS rats.
Methods: Adolescent female Sprague Dawley rats were assigned to groups: not restrained‐saline (NRS), not restrained‐PSI (NRP), restrained‐saline (RS), and restrained‐PSI (RP). RS and RP rats were restrained 1 hr/day post‐natal days (PND) 32–45. Rats received IP PSI (1 mg/kg) or saline PND 52. The OPS task was performed nightly PND 82 (0 cm) – 86 (24 cm) in a 66 cm diameter arena containing two identical objects, one of which was moved from 0 cm to 6, 12, 18, and 24 cm from 0 following an hour intertrial interval. FST was performed PND 89–90.
Results: Significant discrimination in the OPS at 24 cm was observed in NRS ( p <0.001), NRP ( p <0.0001), and RP ( p <0.01), but RS rats were unable to discriminate between moved and stationary objects. RS rats were significantly more immobile in the FST than NRS rats ( p <0.0001). No differences were observed between NRS, NRP, and RP rats. Immobility in the FST was inversely correlated to discrimination in the OPS at 24 cm (r=−0.402, p =0.023).
Conclusions: The OPS is a translationally relevant outcome with face and predictive validity, correlates with an established measure of depressive‐like behavior, and can be used in female rats. One dose of PSI in late adolescence mitigates cognitive and behavioral deficiencies characteristic of the developmentally‐stressed adult aCRS rat model for depression. Our aCRS model is uniquely suitable for elucidating the antidepressant mechanisms of PSI, which has translationally relevant antidepressant‐like effects that can be measured using the OPS task, many weeks after administration. Support or Funding Information This work supported by Eleusis, PBC.
Comparable studies
Other preclinical and animal studies on psilocybin, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo Mice | 2021 | Observational cohort | |
| Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice Mice | 2021 | Experimental study | |
| Psychedelics reopen the social reward learning critical period Mice | 2023 | Experimental study in mice | |
| Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species. C57BL/6J mice | 2020 | Experimental study with dose-response experiments | |
| Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning Mice | 2013 | Experimental study |
Citations in the library
Cited by 9
- Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin Journal of Psychopharmacology November 4, 2020
- Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach Neurobiology of Learning and Memory May 25, 2021
- Pharmahuasca and DMT Rescue ROS Production and Differentially Expressed Genes Observed after Predator and Psychosocial Stress: Relevance to Human PTSD. ACS Chemical Neuroscience January 6, 2022
- A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review. CNS Drugs October 1, 2022
- How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework. Psychopharmacology March 29, 2022
and 4 more in the library